XML 18 R6.htm IDEA: XBRL DOCUMENT v3.25.3
Unaudited Consolidated Statements of Stockholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Common Stock
Additional Paid-In Capital
Retained Earnings
Treasury Stock
Accumulated Other Comprehensive Loss, Net of Tax
Non-controlling Interests In Consolidated Subsidiary
Balance (in shares) at Dec. 31, 2023   321          
Balance (in shares) at Dec. 31, 2023         (6)    
Balance at beginning of period at Dec. 31, 2023 $ 10,543 $ 3 $ 2,901 $ 8,434 $ (784) $ (12) $ 1
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 454     454      
Other comprehensive income (loss) 7         7  
Cash dividends declared (169)     (169)      
Issuances of common stock (25)   3   $ (28)    
Stock-based compensation 11   12 (1)      
Balance (in shares) at Mar. 31, 2024   321          
Balance (in shares) at Mar. 31, 2024         (6)    
Balance at end of period at Mar. 31, 2024 10,821 $ 3 2,916 8,718 $ (812) (5) 1
Balance (in shares) at Dec. 31, 2023   321          
Balance (in shares) at Dec. 31, 2023         (6)    
Balance at beginning of period at Dec. 31, 2023 10,543 $ 3 2,901 8,434 $ (784) (12) 1
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 1,531            
Other comprehensive income (loss) (7)            
Balance (in shares) at Sep. 30, 2024   321          
Balance (in shares) at Sep. 30, 2024         (8)    
Balance at end of period at Sep. 30, 2024 11,230 $ 3 2,946 9,444 $ (1,145) (19) 1
Balance (in shares) at Mar. 31, 2024   321          
Balance (in shares) at Mar. 31, 2024         (6)    
Balance at beginning of period at Mar. 31, 2024 10,821 $ 3 2,916 8,718 $ (812) (5) 1
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 512     512      
Other comprehensive income (loss) (4)         (4)  
Cash dividends declared (168)     (168)      
Issuances of common stock 4   5   $ (1)    
Stock-based compensation 10   11 (1)      
Purchase of common stock for treasury (in shares)         (1)    
Purchase of common stock for treasury (169)       $ (169)    
Balance (in shares) at Jun. 30, 2024   321          
Balance (in shares) at Jun. 30, 2024         (7)    
Balance at end of period at Jun. 30, 2024 11,006 $ 3 2,932 9,061 $ (982) (9) 1
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 566     566      
Other comprehensive income (loss) (10)         (10)  
Cash dividends declared (182)     (182)      
Issuances of common stock 4   4        
Stock-based compensation 9   10 (1)      
Purchase of common stock for treasury (in shares)         (1)    
Purchase of common stock for treasury (163)       $ (163)    
Balance (in shares) at Sep. 30, 2024   321          
Balance (in shares) at Sep. 30, 2024         (8)    
Balance at end of period at Sep. 30, 2024 $ 11,230 $ 3 2,946 9,444 $ (1,145) (19) 1
Balance (in shares) at Dec. 31, 2024   313          
Balance (in shares) at Dec. 31, 2024 (1)       (1)    
Balance at beginning of period at Dec. 31, 2024 $ 11,407 $ 3 1,767 9,774 $ (113) (26) 2
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 495     495      
Other comprehensive income (loss) (5)         (5)  
Cash dividends declared (181)     (181)      
Issuances of common stock (19)   3   (22)    
Stock-based compensation 13   14 (1)      
Purchase of common stock for treasury (45)       $ (45)    
Balance (in shares) at Mar. 31, 2025   313          
Balance (in shares) at Mar. 31, 2025         (1)    
Balance at end of period at Mar. 31, 2025 $ 11,665 $ 3 1,784 10,087 $ (180) (31) 2
Balance (in shares) at Dec. 31, 2024   313          
Balance (in shares) at Dec. 31, 2024 (1)       (1)    
Balance at beginning of period at Dec. 31, 2024 $ 11,407 $ 3 1,767 9,774 $ (113) (26) 2
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 1,595            
Other comprehensive income (loss) $ (5)         (5)  
Cash dividends declared       (557)      
Balance (in shares) at Sep. 30, 2025   313          
Balance (in shares) at Sep. 30, 2025 (3)       (3)    
Balance at end of period at Sep. 30, 2025 $ 11,872 $ 3 1,816 10,810 $ (727) (31) 1
Balance (in shares) at Mar. 31, 2025   313          
Balance (in shares) at Mar. 31, 2025         (1)    
Balance at beginning of period at Mar. 31, 2025 11,665 $ 3 1,784 10,087 $ (180) (31) 2
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 550     550      
Other comprehensive income (loss) 3         3  
Cash dividends declared (182)     (182)      
Issuances of common stock 5   6   $ (1)    
Stock-based compensation 11   11        
Balance (in shares) at Jun. 30, 2025   313          
Balance (in shares) at Jun. 30, 2025         (1)    
Balance at end of period at Jun. 30, 2025 12,052 $ 3 1,801 10,455 $ (181) (28) 2
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 550     550      
Other comprehensive income (loss) (3)         (3)  
Cash dividends declared (194)     (194)      
Issuances of common stock 4   5   $ (1)    
Stock-based compensation 9   10 (1)      
Purchase of common stock for treasury (in shares)         (2)    
Purchase of common stock for treasury (545)       $ (545)    
Distributions paid $ (1)           (1)
Balance (in shares) at Sep. 30, 2025   313          
Balance (in shares) at Sep. 30, 2025 (3)       (3)    
Balance at end of period at Sep. 30, 2025 $ 11,872 $ 3 $ 1,816 $ 10,810 $ (727) $ (31) $ 1